Crossmark

Estimating the prevalence of poor-quality anti-TB medicines: a neglected risk for global TB control and resistance

Crossref DOI link: https://doi.org/10.1136/bmjgh-2023-012039

Published Online: 2023-07-11

Published Print: 2023-07

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Tabernero, Patricia https://orcid.org/0000-0002-1015-6207
Newton, Paul N https://orcid.org/0000-0003-0734-2022
Funding

Funding for this research was provided by:

Wellcome Trust (202935/Z/16/Z)
License Information

License valid from 2023-07-11